Managing nonteratogenic adverse reactions to isotretinoin treatment for acne vulgaris

Authors

Bridget K. Reilly, University of Nebraska Medical Center
Tamara S. Ritsema, University of Nebraska Medical Center

Document Type

Journal Article

Publication Date

1-1-2015

Journal

Journal of the American Academy of Physician Assistants

Volume

28

Issue

7

DOI

10.1097/01.JAA.0000459815.24908.02

Keywords

Bowel disease; Depression; Inflammatory; Isotretinoin; Nodulocystic acne; Vertebral hyperostosis

Abstract

Copyright © 2015 American Academy of Physician Assistants. Isotretinoin is the strongest, most effective oral treatment for patients with severe acne vulgaris, with remission rates of 89% and higher. Because of its potency, isotretinoin causes many adverse reactions. This article reviews common and severe adverse reactions to isotretinoin and how providers can best manage these reactions. Because of inconclusive research on the correlation between isotretinoin and depression and inflammatory bowel disease, providers should ask patients about symptoms monthly. Prescribing micronized isotretinoin and starting at the lowest dose with gradual upward titration also can help reduce the incidence of adverse reactions.

APA Citation

Reilly, B., & Ritsema, T. (2015). Managing nonteratogenic adverse reactions to isotretinoin treatment for acne vulgaris. Journal of the American Academy of Physician Assistants, 28 (7). http://dx.doi.org/10.1097/01.JAA.0000459815.24908.02